What to watch—and watch out for—in the bottom half of '07
Jul 3, 2007
As generics manufacturers grow more aggressive, will branded companies follow suit by deploying thorough patent strategies—and crack legal teams? Will government efforts in Japan finally bring cancer out of the shadows and spur oncology sales? Will the adoption of intellectual property rights drive pharma growth in India and help push the country to the top tier of global economic powers? These questions point to developments—some of them flying beneath the radar—that we expect to have major implications for pharmaceutical companies down the road. Each year, IMS identifies the key events that it believes will have a significant impact on the global pharmaceutical market. Here, we reveal those events—the harbingers of change—that will define and reshape the market through 2007 and for years to come.